Alumis ALMS
NASDAQ ALMS
$6.85 -0.36 (-4.99%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alumis (ALMS) Net Income (2023 - 2026)

Updated

Alumis (ALMS) posted Net Income of -$142.18 million for Q2 2026, compared with $59.36 million a year earlier.

Analysis

Alumis (ALMS) Net Income (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Income at Alumis was -$286.5 million; for FY2025, it came in at -$243.29 million.

  • In prior years, Alumis' Net Income was -$294.23 million in FY2024 and -$158.17 million in FY2023.
  • The Q2 2026 figure stands as the lowest quarterly Net Income in data going back to Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.62 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.51 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -237.00 Mn
10 Alumis 852.45 Mn -822.39 Mn - -142.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -142.18 Mn
Dec 31, 2025 -92.93 Mn
Sep 30, 2025 -110.75 Mn
Jun 30, 2025 59.36 Mn
Mar 31, 2025 -101.53 Mn
Dec 31, 2024 -94.76 Mn
Sep 30, 2024 -93.12 Mn
Jun 30, 2024 -56.51 Mn
Mar 31, 2024 -47.59 Mn
Dec 31, 2023 -40.13 Mn
Sep 30, 2023 -43.76 Mn
Jun 30, 2023 -36.71 Mn
API Access

Alumis Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=ALMS&period=max&api_key=YOUR_API_KEY